Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth factor gradients in vascular patterning.

Andrea Lundkvist1, Sunyoung Lee, Luisa Iruela-Arispe

  • 1Vascular Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.

Novartis Foundation Symposium
|February 28, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artery-Like Smooth Muscle Drives Contractile Function in Dural Venous Sinuses.

bioRxiv : the preprint server for biology·2026
Same author

GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brain.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

FGFR signaling establishes spatial gradients of secretory cell identities along the airway proximal-distal axis.

Nature communications·2026
Same author

BMAL1 modulates glutamine supply to control haematopoietic stem and progenitor cell expansion.

Development (Cambridge, England)·2026
Same author

Loss of meningeal lymphatic endothelial cells results in formation of a newly forming vascular network with scavenging function.

Development (Cambridge, England)·2026
Same author

Distinguishing subtypes of endothelial cells in the mouse aorta.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same journal

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Novartis Foundation symposium·2009
Same journal

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Novartis Foundation symposium·2009
Same journal

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Novartis Foundation symposium·2009
Same journal

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Novartis Foundation symposium·2009
Same journal

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.

Novartis Foundation symposium·2009
Same journal

CD8 and cytotoxic T cells in type 1 diabetes.

Novartis Foundation symposium·2009
See all related articles

Vascular Endothelial Growth Factor-A (VEGF-A) gradients guide new blood vessel growth. In pathological neovascularization, matrix metalloproteases (MMP) cleave VEGF-A, disrupting these gradients and causing abnormal vessel patterning.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Ophthalmology

Background:

  • Growth factor gradients are crucial for developmental processes like angiogenesis.
  • Vascular Endothelial Growth Factor-A (VEGF-A) gradients direct new blood vessel sprouting.
  • VEGF-A retention, mediated by heparin-binding motifs in longer isoforms (VEGF164, VEGF188), is essential for gradient formation.

Purpose of the Study:

  • To investigate the role of VEGF-A retention in regulating endothelial tip cell guidance and stalk cell proliferation during retinal angiogenesis.
  • To identify mechanisms disrupting VEGF-A gradients in pathological neovascularization.
  • To explore therapeutic strategies targeting VEGF-A gradient disruption in ocular diseases.

Main Methods:

  • Comparative study of developmental angiogenesis and pathological neovascularization in mouse retinas.

Related Experiment Videos

  • Investigated the impact of VEGF-A isoform-specific properties (e.g., VEGF120 vs. longer isoforms) on endothelial cell migration.
  • Utilized genetic and pharmacological approaches to inhibit macrophage infiltration and matrix metalloprotease (MMP) activity.

    • Main Results:

    • Loss of VEGF-A retention disrupts endothelial tip cell guidance and stalk cell proliferation control in pathological neovascularization.
    • Proteolytic cleavage of VEGF-A by MMPs, primarily from infiltrating macrophages, causes this loss of retention.
    • Inhibition of macrophage infiltration or MMP activity rescued guided revascularization, reducing pre-retinal neovascularization.

    Conclusions:

    • Disruption of VEGF-A gradients, through MMP-mediated cleavage, is a key mechanism in pathological neovascularization of the retina.
    • Targeting macrophage-derived MMPs offers a potential therapeutic strategy for controlling aberrant ocular neovascularization.
    • Restoring functional VEGF-A gradients may be crucial for treating blinding eye diseases characterized by neovascularization.